Edwards Lifesciences Corporation (EW)
USD 72.81
(-1.77%)
USD 72.81
(-1.77%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 2.31 USD | -6.1% |
| 2022 | 2.46 USD | 2.07% |
| 2021 | 2.41 USD | 82.58% |
| 2020 | 1.32 USD | -21.43% |
| 2019 | 1.68 USD | 46.09% |
| 2018 | 1.15 USD | 17.35% |
| 2017 | 0.98 USD | 10.11% |
| 2016 | 0.89 USD | 15.58% |
| 2015 | 0.77 USD | -39.37% |
| 2014 | 1.27 USD | 115.25% |
| 2013 | 0.59 USD | 37.21% |
| 2012 | 0.43 USD | 22.86% |
| 2011 | 0.35 USD | 9.37% |
| 2010 | 0.32 USD | -5.88% |
| 2009 | 0.34 USD | 78.95% |
| 2008 | 0.19 USD | 18.75% |
| 2007 | 0.16 USD | -15.79% |
| 2006 | 0.19 USD | 72.73% |
| 2005 | 0.11 USD | 4300.0% |
| 2004 | 0.00 USD | -97.73% |
| 2003 | 0.11 USD | 40.49% |
| 2002 | 0.08 USD | 560.59% |
| 2001 | -0.02 USD | 95.64% |
| 2000 | -0.39 USD | -425.0% |
| 1999 | 0.12 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.58 USD | -4.92% |
| 2024 Q3 | 5.14 USD | 742.62% |
| 2024 Q2 | 0.61 USD | 5.17% |
| 2023 Q3 | 0.63 USD | 23.53% |
| 2023 Q4 | 0.61 USD | -3.17% |
| 2023 FY | - USD | -6.1% |
| 2023 Q1 | 0.56 USD | -13.85% |
| 2023 Q2 | 0.51 USD | -8.93% |
| 2022 Q1 | 0.60 USD | 11.11% |
| 2022 FY | - USD | 2.07% |
| 2022 Q3 | 0.55 USD | -15.38% |
| 2022 Q2 | 0.65 USD | 8.33% |
| 2022 Q4 | 0.65 USD | 18.18% |
| 2021 FY | - USD | 82.58% |
| 2021 Q1 | 0.54 USD | 8.0% |
| 2021 Q3 | 0.55 USD | -30.38% |
| 2021 Q2 | 0.79 USD | 46.3% |
| 2021 Q4 | 0.54 USD | -1.82% |
| 2020 Q2 | -0.20 USD | -140.0% |
| 2020 Q1 | 0.50 USD | 11.11% |
| 2020 Q4 | 0.50 USD | -3.85% |
| 2020 Q3 | 0.52 USD | 360.0% |
| 2020 FY | - USD | -21.43% |
| 2019 Q4 | 0.45 USD | 2.27% |
| 2019 Q1 | 0.40 USD | 3900.0% |
| 2019 Q2 | 0.39 USD | -2.5% |
| 2019 Q3 | 0.44 USD | 12.82% |
| 2019 FY | - USD | 46.09% |
| 2018 Q3 | 0.36 USD | -20.0% |
| 2018 FY | - USD | 17.35% |
| 2018 Q2 | 0.45 USD | 36.36% |
| 2018 Q1 | 0.33 USD | 484.07% |
| 2018 Q4 | 0.01 USD | -97.22% |
| 2017 Q1 | 0.36 USD | 44.0% |
| 2017 FY | - USD | 10.11% |
| 2017 Q4 | 0.06 USD | -79.07% |
| 2017 Q2 | 0.29 USD | -19.44% |
| 2017 Q3 | 0.27 USD | -6.9% |
| 2016 Q3 | 0.22 USD | 10.0% |
| 2016 Q2 | 0.20 USD | -9.09% |
| 2016 Q4 | 0.25 USD | 13.64% |
| 2016 Q1 | 0.22 USD | 0.0% |
| 2016 FY | - USD | 15.58% |
| 2015 FY | - USD | -39.37% |
| 2015 Q4 | 0.22 USD | 22.22% |
| 2015 Q2 | 0.18 USD | -5.26% |
| 2015 Q3 | 0.18 USD | 0.0% |
| 2015 Q1 | 0.19 USD | 11.76% |
| 2014 Q4 | 0.17 USD | 13.33% |
| 2014 Q3 | 0.15 USD | -82.56% |
| 2014 FY | - USD | 115.25% |
| 2014 Q2 | 0.86 USD | 805.26% |
| 2014 Q1 | 0.10 USD | -20.83% |
| 2013 Q2 | 0.14 USD | -33.33% |
| 2013 FY | - USD | 37.21% |
| 2013 Q4 | 0.12 USD | 0.0% |
| 2013 Q3 | 0.12 USD | -14.29% |
| 2013 Q1 | 0.21 USD | 61.54% |
| 2012 Q2 | 0.10 USD | 3.47% |
| 2012 Q1 | 0.10 USD | 3.6% |
| 2012 Q3 | 0.10 USD | 1.73% |
| 2012 FY | - USD | 22.86% |
| 2012 Q4 | 0.13 USD | 30.0% |
| 2011 Q3 | 0.08 USD | -11.76% |
| 2011 Q4 | 0.09 USD | 22.27% |
| 2011 Q1 | 0.09 USD | -1.89% |
| 2011 FY | - USD | 9.37% |
| 2011 Q2 | 0.08 USD | -8.9% |
| 2010 Q4 | 0.10 USD | 35.86% |
| 2010 FY | - USD | -5.88% |
| 2010 Q1 | 0.07 USD | -0.43% |
| 2010 Q2 | 0.08 USD | 21.43% |
| 2010 Q3 | 0.07 USD | -17.65% |
| 2009 FY | - USD | 78.95% |
| 2009 Q4 | 0.07 USD | -36.09% |
| 2009 Q3 | 0.11 USD | 55.37% |
| 2009 Q2 | 0.07 USD | -21.33% |
| 2009 Q1 | 0.09 USD | 58.73% |
| 2008 Q2 | 0.06 USD | 124.72% |
| 2008 FY | - USD | 18.75% |
| 2008 Q4 | 0.06 USD | 15.24% |
| 2008 Q3 | 0.05 USD | -18.0% |
| 2008 Q1 | 0.03 USD | 15.58% |
| 2007 Q2 | 0.05 USD | 6.95% |
| 2007 Q3 | 0.04 USD | -16.34% |
| 2007 Q1 | 0.05 USD | 60.47% |
| 2007 Q4 | 0.02 USD | -45.65% |
| 2007 FY | - USD | -15.79% |
| 2006 Q1 | 0.06 USD | 19.33% |
| 2006 Q2 | 0.05 USD | -20.87% |
| 2006 FY | - USD | 72.73% |
| 2006 Q3 | 0.04 USD | -21.26% |
| 2006 Q4 | 0.03 USD | -26.0% |
| 2005 Q4 | 0.05 USD | 981.97% |
| 2005 Q1 | 0.04 USD | 19.61% |
| 2005 Q2 | 0.02 USD | -55.66% |
| 2005 Q3 | -0.01 USD | -131.77% |
| 2005 FY | - USD | 4300.0% |
| 2004 Q2 | 0.04 USD | 141.24% |
| 2004 FY | - USD | -97.73% |
| 2004 Q4 | 0.04 USD | 106.86% |
| 2004 Q3 | 0.02 USD | -51.12% |
| 2004 Q1 | -0.09 USD | -426.32% |
| 2003 Q4 | 0.03 USD | -22.22% |
| 2003 Q1 | 0.02 USD | -32.47% |
| 2003 Q2 | 0.03 USD | 44.23% |
| 2003 Q3 | 0.03 USD | 14.0% |
| 2003 FY | - USD | 40.49% |
| 2002 FY | - USD | 560.59% |
| 2002 Q2 | 0.04 USD | 48.29% |
| 2002 Q4 | 0.03 USD | 224.7% |
| 2002 Q3 | -0.02 USD | -157.04% |
| 2002 Q1 | 0.03 USD | 25.32% |
| 2001 Q2 | -0.08 USD | -531.15% |
| 2001 Q3 | 0.02 USD | 126.36% |
| 2001 FY | - USD | 95.64% |
| 2001 Q4 | 0.02 USD | 12.02% |
| 2001 Q1 | 0.02 USD | -48.31% |
| 2000 FY | - USD | -425.0% |
| 2000 Q1 | 0.02 USD | -71.99% |
| 2000 Q2 | -0.44 USD | -1918.18% |
| 2000 Q3 | 0.01 USD | 101.52% |
| 2000 Q4 | 0.04 USD | 428.36% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | 0.09 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Abbott Laboratories | 3.30 USD | 30.0% |
| Allurion Technologies Inc. | -2.31 USD | 200.0% |
| Artivion, Inc. | -0.75 USD | 408.0% |
| Avanos Medical, Inc. | -1.33 USD | 273.684% |
| Butterfly Network, Inc. | -0.65 USD | 455.385% |
| Butterfly Network, Inc. | -0.65 USD | 455.385% |
| Bio-Rad Laboratories, Inc. | -21.82 USD | 110.587% |
| Boston Scientific Corporation | 1.08 USD | -113.889% |
| Perspective Therapeutics, Inc. | -0.10 USD | 2410.0% |
| CONMED Corporation | 2.10 USD | -10.0% |
| Paragon 28, Inc. | -0.58 USD | 498.276% |
| Glaukos Corporation | -2.78 USD | 183.094% |
| Globus Medical, Inc. | 1.09 USD | -111.927% |
| Inspire Medical Systems, Inc. | -0.72 USD | 420.833% |
| Integer Holdings Corporation | 2.72 USD | 15.074% |
| Medtronic plc | 2.77 USD | 16.606% |
| Nevro Corp. | -2.56 USD | 190.234% |
| Owlet, Inc. | -4.53 USD | 150.993% |
| Penumbra, Inc. | 2.37 USD | 2.532% |
| Vicarious Surgical Inc. | -0.49 USD | 571.429% |
| Smith & Nephew plc | 0.60 USD | -285.0% |
| Sonendo, Inc. | -0.65 USD | 455.385% |
| STERIS plc | 3.83 USD | 39.687% |
| Stryker Corporation | 8.34 USD | 72.302% |
| Vapotherm, Inc. | -9.64 USD | 123.963% |
| Zimmer Biomet Holdings, Inc. | 4.91 USD | 52.953% |